دوره 2، شماره 1 - ( 3-1401 )
جلد 2 شماره 1 صفحات 36-26 |
برگشت به فهرست نسخه ها
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Shojaat S. The Corona Pandemic: A Review of Corona Features, Evaluation, and Treatment. Zoonosis 2022; 2 (1) :26-36
URL: http://zoonosis.ir/article-1-40-fa.html
URL: http://zoonosis.ir/article-1-40-fa.html
شجاعت شادان. همه گیری کرونا: مطالعه مروری بر ویژگی ها، ارزیابی و درمان کرونا. مجله بيماری های قابل انتقال بين انسان و حيوان. 1401; 2 (1) :26-36
، shaadaansh@gmail.com
چکیده: (689 مشاهده)
در پایان دسامبر سال 2019، یک بیماری جدید که اتیولوژی آن ناشناخته بود در ووهان چین ظاهر شد و به سرعت به عنوان یک betacoronavirus جدید شناخته شد که دارای ارتباط نزدیک با SARS-CoV و تعدادی دیگر از ویروس‌های کرونای مشابه - SARS بامنشا خفاش میباشد. این ویروس از خفاش‌ها منشاء گرفته و از طریق حیوانات واسطه‌ای‌که هنوز ناشناخته اند در ووهان، استان هوبی به انسان منتقل میشود. این ویروس به سرعت در کلیه استانهای چین و با همان سرعت در کشورهای دیگر گسترش یافت که موجب آن شد که مدیرکل سازمان بهداشت جهانی در 30 ژانویه 2020 از بابت سلامتی عمومی اظهار نگرانی نماید. این بیماری از طریق استنشاق یا تماس با قطرات آلوده منتقل میشود و دوره کمون آن بین 2 تا 14 روز است. علائم معمولاً می‌تواند شامل تب، سرفه، گلودرد، تنگی نفس، خستگی، کسالت و غیره باشد. دراین مقاله شیوع ناگهانی و ویژگی‌های شناخته شده ویروس نوپدید SARS-CoV-2، بیماری بالینی ناشی شده از آن، COVID-19 و خلا‌های مهم در دانش ما از شناخت ویروس و علت‌های بیماری بررسی شده است.
مرور کتاب: مروری |
دریافت: 1401/3/16 | پذیرش: 1401/3/27 | انتشار: 1401/3/30
دریافت: 1401/3/16 | پذیرش: 1401/3/27 | انتشار: 1401/3/30
فهرست منابع
1. He F, Deng Y, Li W. Coronavirus disease 2019: What we know? Journal of medical virology. 2020;92(7):719-725. [DOI:10.1002/jmv.25766] [PMID] [PMCID]
2. Mackenzie JS, Smith DW. COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don't. Microbiology Australia. 2020;41(1):45-50. [DOI:10.1071/MA20013] [PMID] [PMCID]
3. Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. New England journal of medicine. 2020; [DOI:10.1056/NEJMoa2001017] [PMID] [PMCID]
4. Zhou P, Yang X-L, Wang X-G, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-273. [DOI:10.1038/s41586-020-2012-7] [PMID] [PMCID]
5. Ren L-L, Wang Y-M, Wu Z-Q, et al. Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study. Chinese medical journal. 2020;133(09):1015-1024. [DOI:10.1097/CM9.0000000000000722] [PMID] [PMCID]
6. Lu R, Zhao X, Li J, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. The lancet. 2020;395(10224):565-574. [DOI:10.1016/S0140-6736(20)30251-8]
7. Wu F, Zhao S, Yu B, Chen Y, Wang W, Song Z. A novel coronavirus associated with human respiratory disease in China. Nature. 2020;579(7798):265-269. [DOI:10.1038/s41586-020-2008-3] [PMID] [PMCID]
8. Cascella M, Rajnik M, Aleem A, Dulebohn SC, Di Napoli R. Features, evaluation, and treatment of coronavirus (COVID-19). Statpearls [internet]. 2022;
9. Nadeem MS, Zamzami MA, Choudhry H, et al. Origin, potential therapeutic targets and treatment for coronavirus disease (COVID-19). Pathogens. 2020;9(4):307. [DOI:10.3390/pathogens9040307] [PMID] [PMCID]
10. Richman DD, Whitley RJ, Hayden FG. Clinical virology. John Wiley & Sons; 2020.
11. Chan JF-W, Yuan S, Kok K-H, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. The lancet. 2020;395(10223):514-523. 30154-9. [DOI:10.1016/S0140-6736(20)30154-9]
12. Ceraolo C, Giorgi FM. Genomic variance of the 2019‐nCoV coronavirus. Journal of medical virology. 2020;92(5):522-528. [DOI:10.1002/jmv.25700] [PMID] [PMCID]
13. Gorbalenya AE, Baker SC, Baric RS, et al. severe acute respiratory syndrome-related coronavirus: The species and its viruses-a statement of the Coronavirus Study Group. BioRxiv. 2020; [DOI:10.1101/2020.02.07.937862]
14. Coronavirus N. Situation Report-221 .2020. World Health Organization, 2020c Disponível em: https://www who int/docs/default-source/coronaviruse/situation-reports/20200201-sitrep-12-ncov pdf. 2019;
15. Chinese Center for Disease Control and Prevention China's CDCdetects a large number of new coronaviruses in the South China seafood market in Wuhan. Accessed 22 February 2020, 2020. https://www.chinacdc.cn/yw_9324/202001/t20200127_211469.html
16. Huang C, Wang Y, Li X, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. The lancet. 2020;395(10223):497-506. [DOI:10.1016/S0140-6736(20)30183-5]
17. Li Q, Guan X, Wu P, et al. Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. New England journal of medicine. 2020;
18. Yu W-B, Tang G-D, Zhang L, Corlett RT. Decoding the evolution and transmissions of the novel pneumonia coronavirus (SARS-CoV-2/HCoV-19) using whole genomic data. Zoological research. 2020;41(3):247. [DOI:10.24272/j.issn.2095-8137.2020.022] [PMID] [PMCID]
19. Ge X-Y, Li J-L, Yang X-L, et al. Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor. Nature. 2013;503(7477):535-538. [DOI:10.1038/nature12711] [PMID] [PMCID]
20. Chen Y, Guo Y, Pan Y, Zhao ZJ. Structure analysis of the receptor binding of 2019-nCoV. Biochemical and biophysical research communications. 2020;525(1):135-140. [DOI:10.1016/j.bbrc.2020.02.071] [PMID] [PMCID]
21. Lam TT-Y, Jia N, Zhang Y-W, et al. Identifying SARS-CoV-2-related coronaviruses in Malayan pangolins. Nature. 2020;583(7815):282-285. [DOI:10.1038/s41586-020-2169-0] [PMID]
22. Wang L-F, Anderson DE, Mackenzie JS, Merson MH. From Hendra to Wuhan: what has been learned in responding to emerging zoonotic viruses. The lancet. 2020;395(10224): e33-e34. [DOI:10.1016/S0140-6736(20)30350-0]
23. Zhao S, Musa SS, Lin Q, et al. Estimating the unreported number of novel coronavirus (2019-nCoV) cases in China in the first half of January 2020: a data-driven modelling analysis of the early outbreak. Journal of clinical medicine. 2020;9(2):388 [DOI:10.3390/jcm9020388] [PMID] [PMCID]
24. Leung WK, To K-f, Chan PK, et al. Enteric involvement of severe acute respiratory syndrome-associated coronavirus infection. Gastroenterology. 2003;125(4):1011-1017.
https://doi.org/10.1016/S0016-5085(03)01215-0 [DOI:10.1016/j.gastro.2003.08.001]
25. Zhou J, Li C, Zhao G, et al. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. Science advances. 2017;3(11): eaao4966 [DOI:10.1126/sciadv.aao4966] [PMID] [PMCID]
26. Wu JT, Leung K, Leung GM. Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: a modelling study. The lancet. 2020;395(10225):689-697. 27. [DOI:10.1016/S0140-6736(20)30260-9]
27. Tuite AR, Fisman DN. Reporting, epidemic growth, and reproduction numbers for the 2019 novel coronavirus (2019-nCoV) epidemic. Annals of Internal Medicine. 2020;172(8):567-568. [DOI:10.7326/M20-0358] [PMID] [PMCID]
28. Ryu S, Chun BC, of Epidemiology KS. An interim review of the epidemiological characteristics of 2019 novel coronavirus. Epidemiology and health. 2020;42 [DOI:10.4178/epih.e2020006] [PMID] [PMCID]
29. Imai N. Report 3: Transmissibility of 2019-nCoV. WHO Collaborating Centre for Infectious Disease Modelling, MRC Centre for Global Infectious Disease Analysis, J-IDEA, Imperial College London, UK. 2020.
30. Cowling BJ, Leung GM. Epidemiological research priorities for public health control of the ongoing global novel coronavirus (2019-nCoV) outbreak. Eurosurveillance. 2020;25(6):2000110. [DOI:10.2807/1560-7917.ES.2020.25.6.2000110]
31. Backer JA, Klinkenberg D, Wallinga J. Incubation period of 2019 novel coronavirus (2019-nCoV) infections among travellers from Wuhan, China, 20-28 January 2020. Eurosurveillance. 2020;25(5):2000062. Euro Surveill. 25. doi:10.2807/1560-7917.ES.2020.25.5.2000062 [DOI:10.2807/1560-7917.ES.2020.25.5.2000062] [PMID] [PMCID]
32. Zou L, Ruan F, Huang M, et al. SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New England journal of medicine. 2020;382(12):1177-1179. [DOI:10.1056/NEJMc2001737] [PMID] [PMCID]
33. Pan Y, Zhang D, Yang P, Poon LL, Wang Q. Viral load of SARS-CoV-2 in clinical samples. The Lancet infectious diseases. 2020;20(4):411-412. [DOI:10.1016/S1473-3099(20)30113-4]
34. Hoehl S, Rabenau H, Berger A, et al. Evidence of SARS-CoV-2 infection in returning travelers from Wuhan, China. New England journal of medicine. 2020;382(13):1278-1280. [DOI:10.1056/NEJMc2001899] [PMID] [PMCID]
35. Yu P, Zhu J, Zhang Z, Han Y. A familial cluster of infection associated with the 2019 novel coronavirus indicating possible person-to-person transmission during the incubation period. The Journal of infectious diseases. 2020;221(11):1757-1761. [DOI:10.1093/infdis/jiaa077] [PMID] [PMCID]
36. Bai Y, Yao L, Wei T, et al. Presumed asymptomatic carrier transmission of COVID-19. Journal of the American Medical Association. 2020;323(14):1406-1407 [DOI:10.1001/jama.2020.2565] [PMID] [PMCID]
37. Pan X, Chen D, Xia Y, et al. Asymptomatic cases in a family cluster with SARS-CoV-2 infection. The Lancet infectious diseases. 2020;20(4):410-411. [DOI:10.1016/S1473-3099(20)30114-6]
38. To K, Tsang O, Yip CC-Y, et al. Consistent Detection of 2019 Novel Coronavirus in Saliva, Clinical Infectious Diseases. An Official Publication of the Infectious Diseases Society of America; 2020.
39. Singhal T. A review of coronavirus disease-2019 (COVID-19). The indian journal of pediatrics. 2020;87(4):281-286. [DOI:10.1007/s12098-020-03263-6] [PMID] [PMCID]
40. Chen N, Zhou M, Dong X, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. The lancet. 2020;395(10223):507-513. [DOI:10.1016/S0140-6736(20)30211-7]
41. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. Jama. 2020;323(11):1061-1069. [DOI:10.1001/jama.2020.1585] [PMID] [PMCID]
42. Xiao SY, Wu Y, Liu H. Evolving status of the 2019 novel coronavirus infection: Proposal of conventional serologic assays for disease diagnosis and infection monitoring. Journal of medical virology. 2020;92(5):464. [DOI:10.1002/jmv.25702] [PMID] [PMCID]
43. Organization WH. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected: interim guidance, 13 March 2020. 2020.
44. Coopersmith CM, Antonelli M, Bauer SR, et al. The surviving sepsis campaign: research priorities for coronavirus disease 2019 in critical illness. Critical care medicine. 2021;49(4):598-622. [DOI:10.1097/CCM.0000000000004895] [PMID]
45. Alexandridi M, Mazej J, Palermo E, Hiscott J. The coronavirus pandemic-2022: viruses, variants & vaccines. Cytokine & growth factor reviews. 2022; [DOI:10.1016/j.cytogfr.2022.02.002] [PMID] [PMCID]
46. Lu S. Heterologous prime-boost vaccination. Current opinion in immunology. 2009;21(3):346-351. [DOI:10.1016/j.coi.2009.05.016] [PMID] [PMCID]
47. Menachery VD, Yount BL, Debbink K, et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nature medicine. 2015;21(12):1508-1513. [DOI:10.1038/nm.3985] [PMID] [PMCID]
48. Hu B, Zeng L-P, Yang X-L, et al. Discovery of a rich gene pool of bat SARS-related coronaviruses provides new insights into the origin of SARS coronavirus. PLoS pathogens. 2017;13(11):e1006698. [DOI:10.1371/journal.ppat.1006698] [PMID] [PMCID]
49. Dhama K, Khan S, Tiwari R, et al. Coronavirus disease 2019-COVID-19. Clinical microbiology reviews. 2020;33(4): e00028-20. [DOI:10.1128/CMR.00028-20] [PMID] [PMCID]
ارسال پیام به نویسنده مسئول
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
اخلاق نشر
این نشریه با احترام به قوانین اخلاق در نشریات تابع قوانین کمیتۀ اخلاق در انتشار (COPE) می باشد و از آیین نامه اجرایی قانون پیشگیری و مقابله با تقلب در آثار علمی پیروی می نماید.
